Baxter International Inc. (BAX) Financials
BAX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 19.8 billion | 13.8 billion |
| Dec. 31, 2025 | 20.1 billion | 14.0 billion |
| Sept. 30, 2025 | 21.1 billion | 13.9 billion |
| June 30, 2025 | 21.0 billion | 13.8 billion |
BAX Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 76.0 million | 10.0 million |
| Dec. 31, 2025 | 444.0 million | 37.0 million |
| Sept. 30, 2025 | 126.0 million | 35.0 million |
| June 30, 2025 | 68.0 million | 35.0 million |
BAX Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | -15.0 million |
| Dec. 31, 2025 | -1.0 billion |
| Sept. 30, 2025 | -51.0 million |
| June 30, 2025 | 122.0 million |
BAX Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 2.0 billion | 8.6 billion | 224.0 million |
| Dec. 31, 2025 | 2.0 billion | 9.5 billion | 325.0 million |
| Sept. 30, 2025 | 1.7 billion | 8.7 billion | 210.0 million |
| June 30, 2025 | 1.7 billion | 9.5 billion | 225.0 million |
BAX Shares Outstanding
BAX Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 137.0 million | 139.0 million | 728.0 million | - |
| Dec. 31, 2025 | 140.0 million | 126.0 million | 761.0 million | - |
| Sept. 30, 2025 | 111.0 million | 118.0 million | 708.0 million | - |
| June 30, 2025 | 149.0 million | 134.0 million | 718.0 million | - |
BAX Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 2.7 billion | 1.8 billion |
| Dec. 31, 2025 | 3.0 billion | 2.4 billion |
| Sept. 30, 2025 | 2.8 billion | 1.9 billion |
| June 30, 2025 | 2.8 billion | 1.8 billion |
BAX Revenue by Segment
BAX
Price: $22.21
Dividend Yield: 0.89%
Forward Dividend Yield: 0.18%
Payout Ratio: -386.67%
Dividend Per Share: 0.04 USD
Earnings Per Share: -1.91 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 4.7 million
Ebitda: 283.0 millionMarket Capitalization: 11.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 24
DGR3: -5.42%
DGR5: 1.88%
DGR10: 6.89%
DGR20: 11.79%